Exelon (EXC) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
28 Apr, 2026Opening remarks and agenda
The meeting was called to order by the Chairman, with executive leadership and board members present virtually, emphasizing transparency and shareholder participation.
Shareholders were informed about forward-looking statements and associated risks, and the virtual format was highlighted for accessibility.
Over 89% of outstanding shares were represented, establishing quorum for the meeting.
Shareholder proposals
Three proposals were presented: election of nine directors, ratification of PricewaterhouseCoopers as auditor for 2026, and an advisory vote on executive compensation.
The board recommended voting in favor of all proposals.
Overview of voting outcomes
All nine director nominees were elected by majority vote.
PricewaterhouseCoopers was ratified as independent auditor with over 88.9% approval.
Executive compensation for 2025 was approved with over 90.4% of votes cast.
Latest events from Exelon
- Q1 2026 adjusted EPS was $0.91; capital plans and rate base growth remain strong.EXC
Q1 20266 May 2026 - 2025 adjusted EPS rose to $2.77; 2026 guidance targets 6%+ growth and $41.3B capital plan.EXC
Q4 202513 Apr 2026 - Proxy covers director elections, auditor ratification, say-on-pay, and major ESG progress.EXC
Proxy Filing18 Mar 2026 - Votes will be cast on board nominees, auditor ratification, and executive pay at the 2026 meeting.EXC
Proxy Filing18 Mar 2026 - Targeting 5-7% annual earnings growth and $41.3B in capital investment through 2029.EXC
Investor presentation16 Mar 2026 - Q2 2024 adjusted EPS up 15% year-over-year; guidance and long-term growth reaffirmed.EXC
Q2 20242 Feb 2026 - Q3 2024 adjusted EPS rose to $0.71, with robust cash flow and $34.5B in investments planned.EXC
Q3 202417 Jan 2026 - 2024 EPS hit $2.50, $38B capex plan set, and S&P credit rating upgraded to BBB+.EXC
Q4 20248 Jan 2026 - Q1 2025 Adjusted EPS up 35% year-over-year; full-year guidance and growth outlook reaffirmed.EXC
Q1 202525 Dec 2025